INTERNATIONAL WEBINAR ON PHARMACY AND PHARMA NETWORKS

With the continued pressure to reduce costs through innovations and efficiencies all while delivering faster sample results, the use of an On-line Water Bioburden Analyzer (OWBA) is one way companies can meet these demands. OWBA technology has the flexibility to be used for purified water, water for injections or even cleaning verifications and provides real time microbial detection as an early warning for system health. The benefits for using an OWBA include the potential for energy savings through reduced loop sanitation, labor cost reduction and improved product quality and process understanding.

An introduction to study designs for investigating the role of genes in disease will be provided, followed by an overview of statistical methods used to test hypotheses for each design. Examples of several designs will be discussed, as well as accompanying methods. Publications assessing the role of genetic variation in disease will be examined, and a critical critique of methods and results for each publication will be reviewed.

Find out which market-moving events and catalysts to watch for during the upcoming Q1 Outlook Webinar - Key catalysts and their impact on pharma markets. During this webinar recording, industry analysts from Informa Pharma Intelligence present their data-based views on what’s in store for key drugs in early 2019. Discussion include important upcoming events related to these key drugs, their likelihood of phase/PDUFA review success and likelihood of approval, and an examination of the market significance of the drugs themselves.

This webinar will discuss WuXi STA’s practice on overall RSM strategy, focusing on: Starting material evolution, RSM designation, Risk mitigation for potential regulatory push-back